COMMISSION IMPLEMENTING DECISION (EU) 2021/1283

of 2 August 2021

on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular the third subparagraph of Article 89(1) thereof,

Whereas:

(1) Commission Delegated Regulation (EU) No 1062/2014 (2) establishes in its Annex II a list of active substance/product-type combinations included in the review programme of existing active substances in biocidal products on 30 March 2019.

(2) For a number of active substance/product-type combinations included in that list, all the participants have withdrawn or are considered to have withdrawn their support in a timely manner.

(3) In accordance with Article 14(1) of Delegated Regulation (EU) No 1062/2014, the European Chemicals Agency (‘the Agency’) published an open invitation to take over the role of participant for those active substance/product-type combinations for which the role of participant had not previously been taken over. For some of those combinations no notification has been submitted or the notification has been rejected pursuant to Article 17(4) or (5) of that Regulation. Those active substance/product-type combinations which, in accordance with Article 20, first paragraph, point (b), of Delegated Regulation (EU) No 1062/2014, should not be approved for use in biocidal products are the following: metam-sodium (product-types 9 and 11); thiram (product-type 9); bronopol (product-type 9); peroxyoctanoic acid (product-type 2, 3, 4); Malt, ext. – Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from

Hordeum, Gramineae

(product-type 19); 2,2-Dibromo-2-cyanoacetamide (product-type 13).

(4) In addition, in accordance with Article 12(3) of Delegated Regulation (EU) No 1062/2014, the Agency informed the Commission of those active substance/product-type combinations for which all participants have withdrawn or are considered to have withdrawn their support in a timely manner, and for which the role of participant had previously been taken over. Those active substance/product-type combinations which, in accordance with Article 20, first paragraph, point (a), of that Regulation, should not be approved for use in biocidal products are the following: silver, as a nanomaterial (product-types 2, 4, 9);

Eucalyptus citriodora

oil and citronellal, hydrated, cyclized (product-type 19); 2-Hydroxy-α,α,4-trimethylcyclohexanemethanol (product-type 19); chlorine dioxide generated from sodium chlorite and sodium persulfate (product-types 2, 3, 4, 5, 11); amines, C10-16-alkyldimethyl, N-oxides (product-type 4);

Capsicum oleoresin

(product-type 19);

Capsicum annuum

, ext. (product-type 19); reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3-methoxy-2-methylphenyl)-8- methylnonanamide (product-type 19).

(5) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS DECISION:

Article 1

The active substances listed in the Annex are not approved for the product-types indicated therein.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the

Official Journal of the European Union

Done at Brussels, 2 August 2021.

For the Commission

The President

Ursula VON DER LEYEN

(1)

OJ L 167, 27.6.2012, p. 1

(2) Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (

OJ L 294, 10.10.2014, p. 1

ANNEX

Active substance/product-type combinations not approved:

Entry Number in Annex II to Regulation (EU) No 1062/2014	Substance name	Rapporteur Member State	EC number	CAS number	Product-type(s)
9	Bronopol	ES	200-143-0	52-51-7	9
206	Thiram	BE	205-286-2	137-26-8	9
210	Metam-sodium	BE	205-293-0	137-42-8	9, 11
1023	Silver, as a nanomaterial	SE	231-131-3	7440-22-4	2, 4, 9
494	2,2-Dibromo-2-cyanoacetamide (DBNPA)	DK	233-539-7	10222-01-2	13
1047	Eucalyptus citriodora oil and citronellal, hydrated, cyclized	CZ	n/a	n/a	19
609	2-Hydroxy-α,α,4-trimethylcyclohexanemethanol	CZ	255-953-7	42822-86-6	19
813	Peroxyoctanoic acid	FR	n/a	33734-57-5	2, 3, 4
1044	Chlorine dioxide generated from sodium chlorite and sodium persulfate	DE	n/a	n/a	2, 3, 4, 5, 11
1064	Malt, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hordeum, Gramineae	AT	232-310-9	8002-48-0	19
692	Amines, C10-16-alkyldimethyl, N-oxides	PT	274-687-2	70592-80-2	4
1059	Capsicum oleoresin Extractives and their physically modified derivatives. It is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes. (Capsicum frutescens, Solanaceae)	BE	Not available	8023-77-6	19
1060	Capsicum annuum, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Capsicum annuum, Solanaceae.	BE	283-403-6	84625-29-6	19
1061	Reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3- methoxy-2-methylphenyl)-8- methylnonanamide	BE	Not available	Not available	19